ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,892.00
      0.50%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      84.085
      -0.30%
      Bitcoin
      64,766.87
      -0.13%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Agios Pharmaceuticals Inc (AGIO)

      7. Agios Pharmaceuticals Inc (AGIO) Financials

      Agios Pharmaceuticals Inc

      Agios Pharmaceuticals Inc (AGIO)

      NASDAQ
      46.96
      1.08
      (2.35%)
      Closed July 15 4:00PM
      Delayed by 15 minutes
      47.49
      0.53
      (1.13%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Agios Pharmaceuticals Inc Financial Summary

      The current AGIO market cap is 2.67B. The company's latest EPS is USD -6.2017 and P/E is -7.57.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 5.61M6.71M7.4M7.1M8.19M
      Operating Income -90.61M-93.7M-100.9M-106.28M-92.07M
      Net Income -81.02M-83.81M-91.32M-95.94M-81.55M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 117.91M203.2M014.24M26.82M
      Operating Income -426.33M-316.15M-378.42M-389.05M-391.49M
      Net Income -411.47M-327.37M1.6B-231.8M-352.09M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.15B1.09B1.01B937.12M849.71M
      Total Liabilities 114.77M120.92M120.42M126.1M105.79M
      Total Equity 1.04B964.24M886.84M811.02M743.92M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 890.74M852.95M1.44B1.24B937.12M
      Total Liabilities 250.21M453.45M145.76M137.9M126.1M
      Total Equity 640.53M399.5M1.29B1.1B811.02M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -95.18M-161.93M-223.57M-296.06M-99.87M
      Investing 57.6M104.72M144.06M239.58M124.56M
      Financing 2.47M2.7M4.59M5.43M5.86M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -370.62M-290.76M-407.32M-309.48M-296.06M
      Investing 91.44M75.75M1.25B243.26M239.58M
      Financing 289.61M261.52M-765.77M2.35M5.43M

      Stats and Ratios

      Market Cap 2.67B
      Price to Earnings Ratio -7.57
      Price to Sales Ratio 99.39
      Price to Cash Ratio 30.23
      Price to Book Ratio 3.29
      Dividend Yield -

      Share Statistics

      Shares Outstanding 56.77M
      Average Volume (1 week) 707.21k
      Average Volume (1 Month) 721.16k
      52 Week Change 72.27%
      52 Week High 49.055
      52 Week Low 19.795
      Spread (Intraday) 22.67 (45.34%)

      Company Info

      Company Name Agios Pharmaceuticals Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.agios.com
      Industry pharmaceutical preparations (2834)